Statement Of Cash Flows

TAKARA BIO INC. - Filing #7352210

Concept 2023-04-01 to
2023-12-31
As at
2023-12-31
As at
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
As at
2022-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
3,086,000,000 JPY
22,189,000,000 JPY
Interest and dividends received
133,000,000 JPY
80,000,000 JPY
Interest paid
-16,000,000 JPY
-18,000,000 JPY
Income taxes paid
-2,286,000,000 JPY
-9,641,000,000 JPY
Cash flows from operating activities
Net cash provided by (used in) operating activities
482,000,000 JPY
13,261,000,000 JPY
Cash flows from operating activities
Cash flows from investing activities
Net cash provided by (used in) investing activities
-11,740,000,000 JPY
-9,551,000,000 JPY
Other, net
-6,000,000 JPY
8,000,000 JPY
Cash flows from facilities maintenance and investing activities
Cash flows from financing activities
Dividends paid
-5,048,000,000 JPY
-3,967,000,000 JPY
Net cash provided by (used in) financing activities
-5,184,000,000 JPY
-4,076,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
1,146,000,000 JPY
1,418,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-15,296,000,000 JPY
1,052,000,000 JPY
Cash and cash equivalents
33,761,000,000 JPY
49,058,000,000 JPY
23,212,000,000 JPY
22,160,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.